A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Affronti, ML; Woodring, S; Herndon, JE; McSherry, F; Peters, KB; Friedman, HS; Desjardins, A; Freeman, W; Cheshire, S; Cone, C; Kalinowski, KH; Kim, J-Y; Lay, HH; Poillucci, V; Southerland, C; Tetterton, J; Vredenburgh, JJ
Published Date
- October 1, 2012
Published In
Volume / Issue
- 14 /
Start / End Page
- 156 - 156
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Conference Location
- Washington, DC
Conference Start Date
- November 15, 2012
Conference End Date
- November 18, 2012